Medical research

How bile acids could fight diabetes

EPFL scientists have shown that a receptor activated by bile acids can reduce fat-tissue inflammation and insulin resistance in obesity-linked diabetes.

Diseases, Conditions, Syndromes

Dysfunctional ketogenesis promotes fatty liver disease in mice

Approximately 1 billion people worldwide have non-alcoholic fatty liver disease (NAFLD). Individuals with this disease have an increased risk of type 2 diabetes, obesity, and kidney disease. It is not clear how this disease ...

Cardiology

Identification of genetic risk factors for stroke

Stroke is one of the leading causes of death worldwide. While many lines of evidence suggest that stroke risk is heritable, only a small number of genes associated with stroke have been identified.

Oncology & Cancer

Researchers develop improved means of detecting mismatched DNA

Researchers at Johns Hopkins have identified a highly sensitive means of analyzing very tiny amounts of DNA. The discovery, they say, could increase the ability of forensic scientists to match genetic material in some criminal ...

Medications

Gilead to license generic version of Sovaldi (Update)

Gilead Sciences has reached a deal with several generic drugmakers to produce a cheaper version of its popular, $1,000-per-pill hepatitis C drug Sovaldi for use in developing countries.

page 20 from 39